advertisement
Abstract #19306 Published in IGR 9-3
Acute angle-closure glaucoma resulting from treatment with nebulised bronchodilators
Fernandez-Barrientos Y; Jimenez-Santos M; Martinez-de-la-Casa JM; Mendez-Hernandez C; Garcia-Feijoo JArchivos de la Sociedad Española de Oftalmologia 2006; 81: 657-660
CASE REPORT: A 78-year-old woman, with an acute exacerbation of chronic obstructive airways disease, was treated with nebulised ipratropium bromide and salbutamol. Twenty hours after beginning this treatment, she developed acute angle-closure glaucoma (AACG) in her left eye which resolved rapidly with appropriate treatment. DISCUSSION: Nebulised ipratropium bromide and salbutamol increases the intraocular pressure and may cause an AACG in susceptible patients (those with a shallow anterior chamber, hypermetropia, or chronic angle-closure glaucoma). Increased vigilance in such patients treated with these bronchodilators may avoid this adverse effect. Ensuring the mask is correctly fitted, using a T-piece or unvented nebuliser and protective eye wear, are some of the many recommendations made to minimize the development of AACG in these patients. LA: Spanish
Dr. Y. Fernandez-Barrientos, Hospital Clinico Universitario San Carlos, Instituto de Investigaciones Ramon Castroviejo, Madrid, Spain. yferbar@terra.com
Classification:
9.3.1 Acute primary angle closure glaucoma (pupillary block) (Part of: 9 Clinical forms of glaucomas > 9.3 Primary angle closure glaucomas)
9.4.15 Glaucoma in relation to systemic disease (Part of: 9 Clinical forms of glaucomas > 9.4 Glaucomas associated with other ocular and systemic disorders)
